US Patent 11207323 sGC stimulators
Patent 11207323 was granted and assigned to Cyclerion Therapeutics on December, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+271 characters)
Article
Patent abstract
Compounds of Formulae I′ and I are described, which are useful as stimulators of sGC, particularly NO-independent, heme-dependent stimulators. These compounds are also useful for treating, preventing or managing various disorders that are herein disclosed.
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 28 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
112073230
Date of Patent
December 28, 2021
0Patent Application Number
168178300
Date Filed
March 13, 2020
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
112073230
Date of Patent
December 28, 2021
0Patent Application Number
168178300
Date Filed
March 13, 2020
0Official Website
Patent Primary Examiner
Edits on 8 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 30 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11207323 sGC stimulators
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11207323
Date of patent
December 28, 2021
Patent application number
16817830
Date Filed
March 13, 2020
Patent primary examiner
Find more entities like US Patent 11207323 sGC stimulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.